Skip to main content
Wockhardt Limited (NSE:WOCKPHARMA)
India flag India · Delayed Price · Currency is INR
1,515.00
+13.40 (0.89%)
Aug 14, 2025, 3:30 PM IST

Wockhardt Revenue

Wockhardt had revenue of 7.38B INR in the quarter ending June 30, 2025, a decrease of -0.14%. This brings the company's revenue in the last twelve months to 30.34B, up 3.73% year-over-year. In the fiscal year ending March 31, 2025, Wockhardt had annual revenue of 30.35B with 7.24% growth.

Revenue (ttm)
30.34B
Revenue Growth
+3.73%
P/S Ratio
8.17
Revenue / Employee
13.21M
Employees
2,296
Market Cap
247.79B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 202530.35B2.05B7.24%
Mar 31, 202428.30B1.73B6.51%
Mar 31, 202326.57B-5.73B-17.74%
Mar 31, 202232.30B5.22B19.28%
Mar 31, 202127.08B-1.36B-4.78%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Sun Pharmaceutical Industries 537.77B
Divi's Laboratories 96.52B
Cipla 274.80B
Apollo Hospitals Enterprise 217.94B
Mankind Pharma 129.10B
Zydus Lifesciences 232.42B
Fortis Healthcare 80.94B
Aurobindo Pharma 320.25B
Revenue Rankings

Wockhardt News

More News